The companies will continue with their exclusive agreements, including commercialization of their current portfolio
The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The vaccines are currently only authorised for emergency use in the country
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
New role strengthens Quantori’s global leadership position in data science & digital IT
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
Subscribe To Our Newsletter & Stay Updated
